PORTLAND, Ore., June 18, 2025--(BUSINESS WIRE)--Diabetomics has been rebranded Modality Dx. Founded by Dr. Srinivasa Nagalla, Modality Dx is an innovator in rapid test technologies for risk assessment ...
This webinar revisits the foundational assumptions that have shaped data collection strategies in clinical research and asks whether current practice reflects the state of the science or the weight of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results